Curcumin: Research
Overview
This page provides a curated overview of selected peer-reviewed scientific studies examining curcumin, a polyphenolic compound naturally found in turmeric (Curcuma longa). The goal of this page is to provide transparent access to commonly cited research in the scientific literature. The summaries below describe findings reported in published studies. They are presented for educational purposes as part of a clinician-led review of the scientific literature.
Important Context for Readers
Scientific studies examine outcomes in defined populations under specific research conditions. Results reported in individual studies may not apply to all individuals, and findings should not be interpreted as guaranteed outcomes. This page summarizes selected research examining joint comfort, physical function, cardiovascular and metabolic biomarkers, inflammation, oxidative stress, and related biological mechanisms studied in relation to curcumin. It is not intended to provide medical advice, diagnosis, or treatment recommendations. This page is provided for educational purposes and does not include product recommendations or affiliate links.
Summary of Evidence
Across human clinical studies and meta-analyses, curcumin supplementation has been studied for its potential associations with changes in several biomarkers and functional outcomes related to joint health, metabolic health, vascular function, inflammation, and oxidative stress.
While results vary across study populations, formulations, and treatment durations, multiple randomized controlled trials and meta-analyses have reported improvements in measures of joint comfort and physical function, as well as modest improvements in selected metabolic and inflammatory biomarkers. Many studies involve relatively short intervention periods, specialized formulations designed to improve absorption, and surrogate biomarkers rather than long-term clinical outcomes. The studies listed below represent several frequently cited papers within the curcumin literature.
Key Areas of Research
Joint and Physical Function Support
Evidence strength: Moderate to Strong.
Randomized trials and meta-analyses have examined curcumin and turmeric extracts in relation to joint comfort, knee osteoarthritis symptoms, and physical function measures.
1) Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016.
PMID: 27533649
DOI: https://doi.org/10.1089/jmf.2016.3705
Population: Adults with arthritis symptoms across randomized clinical trials.
Design: Systematic review and meta-analysis of randomized clinical trials.
Key findings:
• Curcumin and turmeric extracts were associated with improvements in arthritis-related pain measures.
• Several included studies evaluated individuals with knee osteoarthritis.
• The authors noted variability in study quality, formulations, and sample sizes across included trials.
2) Feng J, Li Z, Tian L, et al. Efficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2022.
PMID: 36261810
DOI: https://doi.org/10.1186/s12906-022-03740-9
Population: Adults with symptomatic knee osteoarthritis.
Design: Systematic review and meta-analysis of randomized controlled trials.
Key findings:
• Curcuminoids were associated with improvements in pain and physical function measures.
• Benefits were observed across several randomized trials involving knee osteoarthritis.
• Heterogeneity and study-quality limitations were noted by the authors.
3) Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010.
PMID: 21194249
DOI: Not listed in PubMed.
Population: Adults with osteoarthritis.
Design: Clinical study evaluating a curcumin-phosphatidylcholine complex (Meriva®).
Key findings:
• Improvements in joint comfort and physical function measures were reported.
• The study evaluated one of the most clinically studied curcumin delivery systems.
• Findings contributed to the evidence base supporting phospholipid-complex curcumin formulations.
Cardiovascular and Metabolic Support
Evidence strength: Moderate.
Human studies and pooled analyses have examined curcumin in relation to lipid biomarkers, metabolic syndrome components, inflammatory markers, and vascular function measures.
4) Qin S, Huang L, Gong J, et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 2017.
PMID: 29020971
DOI: https://doi.org/10.1186/s12937-017-0293-y
Population: Adults with cardiovascular risk factors across randomized controlled trials.
Design: Systematic review and meta-analysis of randomized controlled trials.
Key findings:
• Curcumin supplementation was associated with improvements in selected lipid biomarkers.
• Effects varied across study populations and formulations.
• Additional larger and longer-duration studies were recommended by the authors.
5) Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019.
PMID: 30941814
DOI: https://doi.org/10.1002/ptr.6323
Population: Adults with metabolic syndrome.
Design: Systematic review and meta-analysis of randomized controlled trials.
Key findings:
• Curcumin supplementation was associated with improvements in selected metabolic biomarkers.
• Effects were reported for several glucose-related, lipid-related, and inflammatory outcomes.
• Findings varied according to formulation, dosage, baseline characteristics, and study duration.
6) Qiu L, Gao C, Wang H, et al. Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol. 2023.
PMID: 38945354
DOI: https://doi.org/10.3389/fendo.2023.1216708
Population: Adults with metabolic syndrome across randomized controlled trials.
Design: Systematic review and meta-analysis of randomized controlled trials.
Key findings:
• Curcumin was associated with improvements in several metabolic, inflammatory, and oxidative stress biomarkers.
• Improvements were reported for CRP, TNF-alpha, HDL cholesterol, fasting glucose, and oxidative stress measures in pooled analyses.
• Results varied among endpoints and individual studies.
7) Alidadi M, Sahebkar A, Eslami S, et al. The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Adv Exp Med Biol. 2021.
PMID: 33861432
DOI: https://doi.org/10.1007/978-3-030-64872-5_1
Population: Adults with metabolic syndrome.
Design: Randomized, double-blind, placebo-controlled clinical trial.
Key findings:
• Curcumin supplementation was evaluated for effects on pulse wave velocity, a measure related to arterial stiffness.
• Findings contribute to the emerging vascular-function literature for curcumin.
• Results should be interpreted within the context of a single clinical trial and specific study population.
Antioxidant and Cellular Health Support
Evidence strength: Low to Moderate.
Curcumin has been studied in human trials and mechanistic research for antioxidant, inflammatory, and cellular signaling effects. Clinical evidence is strongest for biomarker changes rather than long-term clinical outcomes.
8) Panahi Y, Hosseini MS, Khalili N, et al. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin Nutr. 2015.
PMID: 25618800
DOI: https://doi.org/10.1016/j.clnu.2014.12.019
Population: Adults with metabolic syndrome.
Design: Randomized controlled trial with updated meta-analysis.
Key findings:
• Curcuminoid-piperine supplementation was associated with changes in inflammatory and oxidative stress biomarkers.
• Reductions in several markers related to inflammation and oxidative stress were reported.
• Findings support continued investigation into curcumin's antioxidant and anti-inflammatory effects.
9) Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology. 2016.
PMID: 27761693
DOI: https://doi.org/10.1007/s10787-016-0289-9
Population: Adults with knee osteoarthritis.
Design: Four-month, randomized, double-blind, placebo-controlled trial.
Key findings:
• Curcuma longa extract was associated with changes in inflammatory and oxidative stress biomarkers.
• The study also contributes to the joint-health literature because it was conducted in individuals with knee osteoarthritis.
• Findings support further investigation into inflammation-related and oxidative-stress-related pathways.
10) Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017.
PMID: 29065496
DOI: https://doi.org/10.3390/foods6100092
Population: Human clinical and translational research literature.
Design: Narrative review.
Key findings:
• Curcumin has been extensively studied for antioxidant, inflammatory, and cellular signaling effects.
• Proposed mechanisms include modulation of inflammatory pathways, oxidative stress responses, and cellular signaling networks.
• Human evidence is strongest for biomarker outcomes and selected clinical applications such as osteoarthritis.
Educational Notice
These summaries are provided for educational purposes to review published scientific literature and should not be interpreted as medical advice, diagnosis, or treatment recommendations. Readers should consult qualified healthcare professionals for personal medical decisions.
FDA Disclaimer
These statements have not been evaluated by the U.S. Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.
FTC Affiliate Disclosure
Some pages on this website may contain affiliate links to products. If readers choose to purchase through those links, the site may receive a commission. Affiliate relationships do not influence the selection or discussion of scientific studies summarized on this reference page.